LDN 91946
CAS No. 439946-22-2
LDN 91946( LDN91946 )
Catalog No. M14496 CAS No. 439946-22-2
LDN 91946 is a selective, uncompetitive ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitor with Ki of 2.8 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 35 | Get Quote |
|
| 25MG | 58 | Get Quote |
|
| 50MG | 87 | Get Quote |
|
| 100MG | 129 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLDN 91946
-
NoteResearch use only, not for human use.
-
Brief DescriptionLDN 91946 is a selective, uncompetitive ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitor with Ki of 2.8 uM.
-
DescriptionLDN 91946 is a selective, uncompetitive ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitor with Ki of 2.8 uM, exhibits no activity against other cysteine hydrolase (UCH-L3, TGase 2, papain and caspase-3).
-
In VitroLDN-91946 is inactive against UCH-L3 at 20 μM. LDN-91946 demonstrates no activity against TGase 2, Papain, and Caspase-3 at 40 μM. There is no cytotoxicity when serum-starved Neuro 2A (N2A) cells are treated with LDN-91946 at concentrations as high as 0.1 mM.
-
In Vivo——
-
SynonymsLDN91946
-
PathwayProteasome/Ubiquitin
-
TargetDUB
-
RecptorDUB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number439946-22-2
-
Formula Weight316.32
-
Molecular FormulaC17H12N6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (265.11 mM)
-
SMILESC1(NC2=CC=CN=C2)=NC=C(C3=NC=NC=C3)C(C4=CC=CO4)=N1
-
Chemical Name3-amino-2-(benzoyl)-6-oxo-7H-thieno[3,2-e]pyridine-5-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mermerian AH, et al. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3729-32.
2. Coulombe J, et al. Front Aging Neurosci. 2014 Jun 19;6:129.
molnova catalog
related products
-
HBX-19818
HBX-19818?is a?potent, selective USP7 inhibitor with IC50 of 28.1 uM.
-
USP7-IN-8
USP7-IN-8 is a selective ubiquitin-specific protease 7 (USP7) inhibitor with an IC50 of 1.4 μM. USP7-IN-8 has anticancer effects.
-
OTUB1/USP8-IN-1
OTUB1/USP8-IN-1 is a potent OTUB1/USP8 inhibitor with potential anticancer activity, demonstrating IC50 values of 0.17 nM for OTUB1 and 0.28 nM for USP8.
Cart
sales@molnova.com